Welcome to our dedicated page for PRICE T ROWE GROUP SEC filings (Ticker: TROW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PRICE T ROWE GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PRICE T ROWE GROUP's regulatory disclosures and financial reporting.
STEVENS ROBERT J reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert J. Stevens received an equity award of 1,899 restricted stock unit shares under the 2017 Non-Employee Director Equity Plan. The award was granted at $105.33 per share and increases his direct holdings to 24,431.665 shares of common stock.
The restricted stock unit shares and accrued dividends will vest in full upon the earlier of next year’s annual meeting, his death, a determination of total and permanent disability, or immediately before a qualifying change in control.
PRICE T ROWE GROUP INC director Cynthia F. Smith received an equity award of 1,899 shares of common stock. The grant is coded as a compensation-related acquisition with no cash paid per share. The award was valued using a share price of $105.33 under the 2017 Non-Employee Director Equity Plan and is structured as restricted stock unit shares that vest upon specific events, including the day before the next annual meeting, death, total and permanent disability, or a change in control. Following this grant, Smith directly holds a total of 8,628.5939 shares.
Rominger Eileen P reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Eileen P. Rominger received a stock grant of 1,899 common shares on May 8, 2026. The award was issued at $105.33 per share under the 2017 Non-Employee Director Equity Plan as restricted Award Shares, with no cash paid by the director.
After this grant, Rominger directly holds 10,867 common shares. The restricted Award Shares and related accrued dividends vest in full upon the earlier of the next year’s annual meeting, death, a determination of Total and Permanent Disability, or immediately before a Change in Control.
MacLellan Robert F. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert F. MacLellan received an equity award of 1,899 shares of common stock in the form of restricted stock units under the 2017 Non-Employee Director Equity Plan. The units were issued at $105.33 per share, matching the TROW share closing price on May 8, 2026, and were granted at no cash cost to him. These stock unit shares and related accrued dividends will fully vest upon the earliest of the first anniversary of the grant date, death, a determination of Total and Permanent Disability, or immediately before a Change in Control. Following this grant, MacLellan directly holds a total of 54,864.8316 shares of TROW common stock.
Golston Allan C. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Allan C. Golston reported receiving an equity award of 1,899 shares of Common Stock with no cash paid per share. This award increased his directly held position to 4,835.2923 shares.
The footnote explains that these shares relate to Restricted Stock Units granted under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share, with vesting contingent on service through the next annual meeting or upon specified events such as death, total and permanent disability, or a change in control.
DUBLON DINA reported acquisition or exercise transactions in this Form 4 filing.
Price T Rowe Group director Dina Dublon received 1,899 shares of restricted common stock as a grant under the 2017 Non-Employee Director Equity Plan. The award is valued at $105.33 per share and vests in full by the next annual meeting or earlier upon death, total and permanent disability, or a change in control. After this grant, she holds 15,424.4541 shares directly and 1,890 shares indirectly through The Dina Dublon Family Trust.
BARTLETT MARK S. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director equity award: Director Mark S. Bartlett received a grant of 1,899 shares of common stock on May 8, 2026 under the 2017 Non-Employee Director Equity Plan at a reference price of $105.33 per share. After this award, he directly holds 35,263 common shares. These restricted shares, along with accrued dividends, will vest in full upon the earlier of the day immediately prior to the next year’s annual meeting, the director’s death, a determination of total and permanent disability, or a change in control, when vesting would occur immediately before and contingent on that event.
DONNELLY WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director William P. Donnelly received a stock award of 1,899 common shares. The shares were granted on May 8, 2026 as a compensation-related award at a reference price of $105.33 per share under the 2017 Non-Employee Director Equity Plan.
Following this grant, Donnelly directly holds a total of 12,466.06 common shares. The restricted stock unit shares, along with related dividends, will fully vest upon the earliest of several events, including the next annual meeting, death, total and permanent disability, or a change in control.
T Rowe Price Group Inc - Schedule 13G filing by Vanguard Capital Management. As of 03/31/2026, Vanguard Capital Management reports beneficial ownership of 16,382,933 shares of common stock, representing 7.52% of the class. The filer reports sole voting power for 2,221,462 shares and sole dispositive power for 16,382,933 shares. The disclosure notes these holdings include securities held by Vanguard funds and certain affiliates over which dispositive or voting power is exercised.
T. Rowe Price Group, Inc. reported first‑quarter 2026 net revenues of $1,857.0 million, up 5.3% from a year earlier, as average assets under management rose 9.6% to $1,775.8 billion.
Net income attributable to the company was $498.2 million versus $490.5 million, with diluted EPS increasing to $2.23 from $2.15. The operating margin improved to 36.6% as revenue growth outpaced a modest 0.8% rise in operating expenses.
Ending assets under management were $1,709.7 billion, down $65.9 billion in the quarter, reflecting $13.7 billion in net outflows and $52.2 billion of market depreciation. The firm recorded a $10.0 million restructuring charge under its expense management program and returned $628.8 million to stockholders through dividends and share repurchases.